Sara H Mohamed
Overview
Explore the profile of Sara H Mohamed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saleh N, Moemen Y, Mohamed S, Fathy G, Ahmed A, Al-Ghamdi A, et al.
Antibiotics (Basel)
. 2022 Jan;
11(1).
PMID: 35052930
DNA gyrase and topoisomerase IV are proven to be validated targets in the design of novel antibacterial drugs. In this study, we report the antibacterial evaluation and molecular docking studies...
2.
Fam N, Mohamed S, Gamal D, Wasfy R, Soliman M, El-Kholy A
Germs
. 2021 Jan;
10(4):303-309.
PMID: 33489945
Introduction: is a challenging pathogen responsible for serious nosocomial infections. Colistin resistance in carbapenem-resistant strains is a critical health problem as it limits the available therapeutic options. The current work...
3.
Fam N, Gamal D, Mohamed S, Wasfy R, Soliman M, El-Kholy A, et al.
Infect Drug Resist
. 2020 Dec;
13:4487-4493.
PMID: 33364795
Purpose: The rise of carbapenem-resistant (CRAB) is considered a public health problem limiting the treatment options. Our current work studied the emergence and mechanisms of colistin-resistance among CRAB isolates in...
4.
Mohamed M, Mostafa H, Mohamed S, El-Moez S, Kamel Z
Microb Drug Resist
. 2020 May;
26(11):1410-1420.
PMID: 32354252
This study aims to evaluate the prevalence of multidrug-resistant (MDR) and biofilm-forming pathogens from animal source compared to clinical ones. In addition, to assess the antibacterial and antibiofilm activity of...